Massoud Motamed

FDA investigator

Appears on 20 documents from 2015 to 2025, most often at sites in Texas. Most often cites production record review (21 CFR 211.192).

20
Documents on file
5.4
Observations per 483
2015
First seen
2025
Most recent

What they cite most

From 105 observations

Activity by year

2015: 3, 2016: 8, 2017: 6, 2025: 3

Where

Texas 7 · India 6 · Arkansas 3 · China 1 · Massachusetts 1 · New Hampshire 1

Is Massoud Motamed coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

20 documents, newest first
FirmOpen
483 FDA Form 483 Celgene Corp July 2025Jul 18, 2025 · Summit, New Jersey
483 Lonza Portsmouth, Inc.Jun 6, 2025 · Portsmouth, New Hampshire
483 FDA Form 483 Ultragenyx Pharmaceutical Inc, Bedford, MA April 2025Apr 25, 2025 · Bedford, Massachusetts
483 Claris Injectables LimitedAug 4, 2017 · Ahmedabad, India
483 Claris Injectables Limited Chacharwadi VasnaJul 27, 2017 · Ahmedabad, India
483 Cantrell Drug CompanyJun 29, 2017 · Little Rock, Arkansas
483 Zhejiang Huahai Pharmaceutical Co., Ltd. Coastal Industrial Zone, Chuannan No. 1 BranchMay 19, 2017 · Dugiao, China

About this profile

What does Massoud Motamed inspect?

Massoud Motamed appears on 20 documents on file covering 16 sites, most often in Texas.

What do they cite most often?

21 CFR 211.192 (production record review), followed by 21 CFR 211.42 and 21 CFR 211.113.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Massoud Motamed is dated Jul 18, 2025.